What is G LNK?
G LNK operates as a sophisticated healthcare data platform engineered to optimize sales and marketing efficacy within the life sciences sector. The company maintains a robust repository of over 9.2 million healthcare professional profiles and granular data on more than 68,000 hospitals and health systems. Through its proprietary suite of tools, G LNK delivers actionable insights, including real-time payment tracking, medical device utilization metrics, and comprehensive prescribing analytics. By facilitating precise identification and engagement with key clinical decision-makers, the platform serves as a critical infrastructure layer for pharmaceutical and medical device organizations seeking to navigate complex healthcare ecosystems with data-driven precision.
How much funding has G LNK raised?
G LNK has raised a total of $500K across 1 funding round:
Angel/Pre-Seed
$500K
Angel/Pre-Seed (2025): $500K with participation from Y Combinator
Key Investors in G LNK
Y Combinator
A premier global startup accelerator and venture capital firm known for identifying and scaling high-growth technology companies through intensive mentorship and early-stage capital.
What's next for G LNK?
With the successful closure of this major strategic investment, G LNK is poised to enter a new phase of operational scaling. The company is expected to prioritize the enhancement of its predictive analytics engine and the expansion of its data coverage to include emerging global markets. As the life sciences industry continues to demand higher transparency and more efficient outreach mechanisms, G LNK's focus on integrating real-time treatment analytics will likely serve as a primary growth driver. The firm's trajectory suggests a transition from a specialized data provider to an essential enterprise partner for global life sciences commercialization teams.
See full G LNK company page
